Literature DB >> 6230102

Pathogenesis of Mooren's ulcer: some new concepts.

P I Murray, A H Rahi.   

Abstract

Mooren's ulcer is a chronic, painful corneal ulceration of unknown aetiology. Recent histological and immunological studies suggest an autoimmune basis. It is now becoming clear that the immune system plays an intricate role in maintaining homoeostasis in health and disease. Regulation of the immune response appears to involve a subset of peripheral blood T lymphocytes known as suppressor cells. A qualitative or quantitative deficiency of suppressor cells may therefore be responsible for chronic inflammation, autoimmune disease, and immunodeficiency states. To explain the reported immunological aberrations the number of suppressor T cells in addition to other immunological parameters were studied in a patient with bilateral Mooren's ulcers. A deficiency of suppressor T cells was found in the peripheral blood. This deficit in the immunoregulatory mechanism explains some of the immunological abnormalities reported in previous studies. Furthermore this study provides additional evidence for an autoimmune aetiology. In the light of these findings the possibility of a new line of treatment has been raised.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6230102      PMCID: PMC1040283          DOI: 10.1136/bjo.68.3.182

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  30 in total

1.  T-lymphocyte maturation: cell surface markers and immune function induced by T-lymphocyte cell-free products and thymosin polypeptides.

Authors:  A Ahmed; D M Wong; G B Thurman; T L Low; A L Goldstein; S J Sharkis; I Goldschneider
Journal:  Ann N Y Acad Sci       Date:  1979       Impact factor: 5.691

2.  Clinical trials with thymosin.

Authors:  J Costanzi; J Daniels; G Thurman; A Goldstein; J Hokanson
Journal:  Ann N Y Acad Sci       Date:  1979       Impact factor: 5.691

3.  Separation of functional subsets of human T cells by a monoclonal antibody.

Authors:  E L Reinherz; P C Kung; G Goldstein; S F Schlossman
Journal:  Proc Natl Acad Sci U S A       Date:  1979-08       Impact factor: 11.205

4.  Effects of thymosin in vitro in cancer patients and correlation with clinical course after thymosin immunotherapy.

Authors:  P B Chretien; S D Lipson; R W Makuch; D E Kenady; M H Cohen
Journal:  Ann N Y Acad Sci       Date:  1979       Impact factor: 5.691

Review 5.  Current concepts in immunology: Regulation of the immune response--inducer and suppressor T-lymphocyte subsets in human beings.

Authors:  E L Reinherz; S F Schlossman
Journal:  N Engl J Med       Date:  1980-08-14       Impact factor: 91.245

6.  Possible ovulation during an ovarian pregnancy.

Authors:  R Dgani; B Czernobilsky; M Lancet; R Borenstein
Journal:  Isr J Med Sci       Date:  1979-07

7.  Direct evidence for loss of human suppressor cells during active autoimmune disease.

Authors:  A J Strelkauskas; R T Callery; J McDowell; Y Borel; S F Schlossman
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

8.  Autoimmune phenomena of the external eye.

Authors:  B J Mondino; S I Brown; B S Rabin
Journal:  Ophthalmology       Date:  1978-08       Impact factor: 12.079

9.  Loss of suppressor T cells in active multiple sclerosis. Analysis with monoclonal antibodies.

Authors:  E L Reinherz; H L Weiner; S L Hauser; J A Cohen; J A Distaso; S F Schlossman
Journal:  N Engl J Med       Date:  1980-07-17       Impact factor: 91.245

10.  The immunopathology of Mooren's ulcer.

Authors:  C S Foster; K R Kenyon; J Greiner; D K Greineder; B Friedland; M R Allansmith
Journal:  Am J Ophthalmol       Date:  1979-08       Impact factor: 5.258

View more
  10 in total

1.  Bilateral Mooren's ulcer in six patients: diagnosis, surgery and histopathology.

Authors:  Christos D Kalogeropoulos; Vassiliki D Malamou-Mitsi; Miltiadis B Aspiotis; Konstantinos G Psilas
Journal:  Int Ophthalmol       Date:  2004-01       Impact factor: 2.031

2.  Immune cells in a case of postherpetic marginal trophic ulcer.

Authors:  K Geboes; A Abu el-Asrar; L Missotten
Journal:  Br J Ophthalmol       Date:  1989-03       Impact factor: 4.638

3.  Circulating antibodies to corneal epithelium in patients with uveitis.

Authors:  P J Kruit; R van der Gaag; L Broersma; A Kijlstra
Journal:  Br J Ophthalmol       Date:  1985-06       Impact factor: 4.638

4.  T-lymphocyte subpopulations in uveitis.

Authors:  P I Murray; W J Dinning; A H Rahi
Journal:  Br J Ophthalmol       Date:  1984-10       Impact factor: 4.638

Review 5.  Ocular inflammatory diseases associated with rheumatoid arthritis.

Authors:  Mathieu Artifoni; Pierre-Raphaël Rothschild; Antoine Brézin; Loïc Guillevin; Xavier Puéchal
Journal:  Nat Rev Rheumatol       Date:  2013-12-10       Impact factor: 20.543

6.  Cyclosporin therapy in Mooren's ulcer.

Authors:  D Wakefield; L P Robinson
Journal:  Br J Ophthalmol       Date:  1987-06       Impact factor: 4.638

7.  Treatment of Mooren's ulcer with cyclosporin A: report of three cases.

Authors:  J C Hill; P Potter
Journal:  Br J Ophthalmol       Date:  1987-01       Impact factor: 4.638

8.  Amniotic Membrane Transplant with a Special Technique (Motowa's Sandwich Technique) in Mooren's Ulcer.

Authors:  Saeed Al Motowa; Mohammed Al Zobidi
Journal:  Middle East Afr J Ophthalmol       Date:  2015 Jul-Sep

Review 9.  Rapid deterioration of Mooren's ulcers after conjunctival flap: a review of 2 cases.

Authors:  Saiqun Li; Yuqing Deng; Caiyuan Du; Haixiang Huang; Jing Zhong; Ling Chen; Bowen Wang; Jin Yuan
Journal:  BMC Ophthalmol       Date:  2017-06-15       Impact factor: 2.209

10.  Corneoscleral graft in Mooren's ulcer: a case report.

Authors:  Mauro Cellini; Michela Fresina; Ernesto Strobbe; Corrado Gizzi; Emilio C Campos
Journal:  Cases J       Date:  2009-11-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.